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ABSTRACT
Enterotoxigenic Escherichia coli (ETEC) is recognized as the main cause of bacterial diarrhoea 
among children in Asia, Africa and Latin America but less investigated in Bolivia. Objective: To 
determine the relation between enterotoxins, CFs and serotypes as well as the antimicrobial resist-
ance patterns in a set of ETEC isolates collected from hospitalized children with acute diarrhea. In 
the present study we characterized 43 ETEC strains isolated from 2002 to 2006 from hospitalized 
children (0-5 years) with acute diarrhea in Bolivia. The strains were analyzed for heat-labile (LT) 
and heat-stable (ST) enterotoxins and colonization factor (CF) profiles, as well as for serogroups 
and antimicrobial resistance using phenotypic (ELISA, dot blot, slide agglutination and disc diffu-
sion) and genotypic (Multiplex PCR) methods. Among the ETEC isolates tested, 30 were positive 
for LT, 3 for STh and 10 for LT/STh. Sixty-five percent (28/43) of the strains expressed one or more 
CF. The most common CFs were CS17 (n = 8) and CFA/I (n = 8). The phenotypical and geno-
typical results for toxins and CFs were congruent except for CS21 that was amplified in 10 of the 
strains by multiplex PCR, but CS21 pili was only detected phenotypically in four of these strains. 
The ETEC strains had diverse O and H antigens and the most common types were O8:H9 LT CS17 
(n = 6; 14%) and O78:HNM LT-ST CFA/I (n = 4; 9%). The analysis of antibiotic resistance showed 
that 67% (n = 29/43) of the strains were resistant to one or several of the antimicrobial agents tested. 
Presence of CFs was associated with antibiotic resistance. Conclusion: The most common toxin 
profile was LT 70%, LT/STh 23% and STh 7%. High antimicrobial resistance to ampicillin among 
serogroups O6, O8 and O78 were the most common.
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INTRODUCTION
Acute diarrheal diseases are an important 
health problem among children under five 
in developing countries and annually cause 
between 1.4 to 2.5 million deaths.1,2 Diar-
rheal diseases cause high rates of pediatric 
morbidity and mortality in Bolivia, leading 
annually to more than 500,000 cases and be-
tween 13,000 and 15,000 deaths respectively.3 
Enterotoxigenic Escherichia coli (ETEC) is an 
important cause of diarrhea among children 
in developing countries and among travel-
ers to ETEC-endemic areas.4 Clinical human 
ETEC isolates produce one or more of three 
enterotoxins; the heat stable toxins (STp and 
STh) and heat labile toxin (LT) and may pro-
duce one or more of several colonization fac-
tors (CFs).5 The CFs mediate adherence to the 
small intestinal mucosa, and to date, more 
than 22 different CFs have been described in 
human ETEC strains (e.g CFA/I, CS1-CS8, 
CS12-CS15, and CS17-CS22).5-8 In developing 
countries, the incidence of ETEC-associated 
diarrhea decreases during the first five years 
of life9 whereas children and adults from in-
dustrialized areas who travel to these coun-
tries are susceptible to this type of diarrhea, 
indicating that natural immunity develops.4,10 
The LT enterotoxin and the CF antigens 
are immunogenic and hence the main candi-
dates for vaccines that are being developed 
against ETEC diarrhea.10,11 Since ETEC strains 
have diverse toxin, CF and serogroup profiles 
it is important to characterize clinical ETEC 
isolates from different parts of the world with 
respect to virulence profiles to evaluate the im-
pact that different vaccine compositions could 
have on ETEC diarrhea. Moreover, antibiotic 
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resistance among ETEC strains is increasing, perhaps due 
to indiscriminate use of antibiotics. Although rehydration 
therapy is the most important part of therapy for acute di-
arrhea, antimicrobials are important adjuvants for therapy 
and their use results in a marked decrease in overall stool 
volume and decreased length of illness. Most cases of bacte-
rial gastroenteritis are self-limiting and in otherwise healthy 
patients, administration of antibiotics is not necessary. How-
ever in infants, elderly people, granulocytopenic or immu-
nodepressed patients with enteritis, and for patients with 
extra-intestinal infections, particularly when bacteremia is 
suspected, antibiotic therapy is fundamental for disease con-
trol.12 The knowledge of antimicrobial resistance patterns 
locally in different countries is important when prescrib-
ing antibiotics for diarrheagenic bacteria, and can serve as a 
guide for implementing public health interventions against 
diarrheal disease.
In this study, we determined the relation between en-
terotoxins, CFs and serotypes, as well as the antimicrobial 
resistance patterns in a set of ETEC isolates collected from 
hospitalized children with acute diarrhea.
MATERIAL AND METHODS
Bacterial strains and determination of toxins and CFs 
ETEC strains were isolated from acute watery non-bloody 
stool samples obtained from hospitalized children with di-
arrhea under five years of age in La Paz, Bolivia, between 
2002-2006. ETEC strains were grown on MacConkey agar 
plates, incubated at 37°C for 18 hours and five lactose posi-
tive colonies were tested for the presence of ETEC toxins 
and CFs by GM1 ELISA, toxin multiplex PCR and dot blot.13 
Confirmed ETEC strains were stored at -70°C in Luria broth 
(Difco) containing 25% glycerol and subsequently shipped 
to Sweden on deep agar stabs. All strains were re-analyzed 
twice by toxin GM1-ELISA, dot blot and Multiplex PCR in 
Sweden.13,14 For the dot blot the MAbs used were CFA/I, CS1 
to CS6, CS8, CS12, CS14, CS17, CS19 and CS21. From the 
original set of ETEC strains (n = 79), we analyzed 43 ETEC 
strains that survived the transport, had identical toxin and 
CF profiles when tested both in Bolivia, Spain and Sweden 
and that were not mixed infections for serotype and antimi-
crobial resistance.
Serotyping
O- and H-antigens were determined according to the meth-
od described by Guinée et al.15 and employing all available 
O (O1-O185) and H (H1-H56) antisera in the E. coli Ref-
erence laboratory (LREC) at the Universidad of Santiago de 
Compostela, Lugo, Spain. All antisera were obtained and ab-
sorbed with the corresponding cross-reacting antigens to re-
move nonspecific agglutinins. The O antisera were produced 
in the LREC and the H antisera were obtained from the Stat-
ens Serum Institute (Copenhagen, Denmark). Isolates that 
did not react with any of the O and H antisera used were 
classified as non-typeable (ONT and HNT), and those that 
were non-motile were denoted HNM.16
Antimicrobial resistance
Colonies from McConkey agar cultures were homogenized 
in 0.85% saline, and the turbidity was adjusted to that of 
a 0.5 McFarland standard. The inoculum suspension was 
spread on a Mueller-Hinton agar plate surface with a swab, 
and incubated in room temperature for 15 min before an-
timicrobial disks were applied. The antimicrobials tested 
were ampicillin, nalidixic acid, chloramphenicol, ampicil-
lin-sulbactam, tetracycline, ciprofloxacin, trimethoprim-
sulfamethoxazole, gentamicin, and cefoxitin. The bacterial 
cultures were incubated for 20 hours at 37°C, and the zone 
of inhibition was determined. The National Committee 
for Clinical Laboratory Standards17 breakpoints were used 
to differentiate between susceptible and resistant isolates. 
E. coli ATCC 25922 was used as a reference strain for quality 
control purposes.
Statistics
The two-tailed Fishers’ exact test was used for statistical 
analysis using the GraphPad InStat Software and a 2 x 2 
contingency table. A p-value less than 0.05 was consid-
ered significant.
RESULTS
ETEC strains were obtained from a prospective study in 
children under five years of age seeking care in three differ-
ent hospitals in La Paz, Bolivia during 2002-2006. The chil-
dren all suffered from non-bloody, acute diarrhea. In total, 
853 clinical samples were analyzed and ETEC was isolated 
from 79 patients. Forty-tree individual ETEC strains isolat-
ed from watery non-bloody diarrhea samples with only one 
microbial pathogen isolated and with confirmed enterotoxin 
and CF expression in La Paz, Santiago de Compostela and 
Gothenburg were selected for further studies (Table 1).
The most common toxin profile among the selected 
strains was LT in 30 strains (70%), followed by LT/STh in 
10 strains (23%) and STh in three strains (7%). The presence 
of STp was not recorded in Bolivia and when analyzed for 
STp in Sweden and in Spain none of the strains harbored 
this toxin. 
The CFs in the selected strains were analyzed both by 
multiplex PCR14 and dot blot.13 Overall, 65% (28/43) of the 
ETEC strains expressed one or more of the 19 CFs analyzed 
in multiplex PCR and results were corroborated by the 
phenotypic analyses and all cases except for CS21. The CFs 
found in the strains were CFA/I (n = 8) and CS17 (n = 8), 
CS1 + CS3 (n = 3), CS2 + CS3 (n = 3), and CS12 (n = 3), 
and CS7 (n = 2), and CS6 (n = 1). CS21 was often found in 
Rodas, Mamani, Blanco et al.
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Table 1. Characterized ETEC strains collected from Bolivian children with diarrhea 
Strain        Children             Characteristics of strains 
 Patient ID Age Sex Toxin  CFsa Serotypeb Antibiotic resistancec,d,e
1 9 18 m F LTSTh CFA/I CS21 O1:H45 AMP, SAM, TET
2 18 15 m M LT CS17 O8:H9 AMP, CHL , SAM
3 19 3 m M LT CS17 O8:H9 AMP, CHL , SAM, TET
4 34 18 m F LTSTh CS1 CS3 CS21 O6:H16 AMP, SAM , SXT
5 95 47 m F LT CS2 CS3 (CS21) O21:HNT -
6 98 13 m M LT CS2 CS3 O21: HNT AMP, CHL TET, SXT, GEN
7 100 48 m F LT - O120:H10 -
8 104 9 m F LT - O174:H40 TET
9 110 12 m F LT - ONT:HNM nt
10 119 11 m F LT CS17 O6:H9 AMP, CHL , SAM
11 121 11 m M LT CS17 O8:H9 AMP, CHL , SAM
12 124 9 m M LT  CS12 O159: H4 AMP, TET, SXT
13 126 17 m M LT - O41:H32 -
14 132 14 m M LT CS17 O8:H9 AMP, SAM , CHL
15 134 24 m F LT CS17 O8:H9 AMP, SAM , SXT
16 137 12 m F STh CS6 (CS21) O148: H28 AMP, SAM , SXT
17 162 14 m M LT CS17 O6: H16 AMP, SAM
18 172 14 m M LT - O120:H10 -
19 174 4 m F LTSTh - O8:H9 -
20 191 16 m M LT - ONT:H40 TET
21 193 19 m F LTSTh CFA/I (CS21) O78:HNM AMP, SAM , SXT
22 204 11 m F LT - O8:H9 AMP, SAM
23 207 5 m M STh CFA/I O153: H45 AMP, SAM , TET
24 220 16 m M LT CS7 O114:H49 TSX
25 226 28 m F LT CS7 O78: H10 AMP, SAM , SXT
26 235 14 m M STh CFA/I CS21 ONT:HNM AMP, SAM , TET
27 237 24 m F LT - ONT:H40 -
28 241 7 m M LT - ONT:HNM AMP, SAM , SXT
29 244 18 m F LTSTh CFA/I (CS21) O78:HNM AMP
30 245 36 m F LT - ONT:H40 -
31 389 9 m M LTSTh CS1 CS3 CS21 O6:H16 AMP, NAL, SXT
32 390 9 m F LTSTh CFA/I (CS21) O78:HNM -
33 409 9 m M LTSTh CFA/I  O6:H16 AMP, NAL, SAM , SXT
34 475 5 m M LT CS1 CS3 ONT:H40 -
35 520 12 m M LT - ONT: HNM AMP. SAM , TET
36 536 17 m M LT - O34:H25 AMP, SAM , TET, SXT, GEN, CEF
37 554 17 m F LT - O159:H4 -
38 574 19 m M LT - ONT:HNM -
39 577 36 m F LT CS17 O8:H9 AMP, SAM , TET, SXT
40 598 14 m F LTSTh CFA/I (CS21) O78:HNM -
41 631 17 m M LT CS12 O159:H21 AMPS, TET, SXT
42 689 6 m M LTSTh CS2 CS3 O1 AMP, SAM
43 743 12 m F LT CS12 O159:H4 -
aCS21 within brackets is positive in PCR but negative in dot blot. 
bNT, non typeable; HNM, non-motile.
cResistant to AMP, ampicillin; SAM, ampicillin sulbactam; CIP, ciprofloxacin; CHL, chloramphenicol; GEN, gentamicin; 
NAL, naldixic acid; CEF, cefoxitin; SXT, trimethoprim; sulfamethoxazole; TET, tetracycline. 
dnt, not tested. 
eAccording to the inhibition halos of the National Committee for Clinical Laboratory Standards for Antimicrobial Disk Susceptibility.
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association with other CFs, especially with CFA/I and the 
CFA/II group (CS1, CS2 and CS3). CS21 was detected by 
multiplex PCR in 10 strains but was only detected by phe-
notypic dot blot test in four of the strains. The pattern of 
phenotypically silent CS21 has previously been reported in 
Bolivian and Bangladeshi strains by us.14 
When analyzing the serogroups of the ETEC strains, 
we found that they belonged to a diverse set of O groups 
(Table 1). Of these serogroups, O6, O8, O78, O114, O120, 
O148, O153 and O159 have frequently been associated 
with ETEC in previous studies18-20 and these 8 O-groups 
were detected in 26 of the 43 ETEC strains. A small num-
ber of additional strains were of O serogroups that have 
infrequently been detected in ETEC strains, namely, O1, 
O41 and O21.19 The remaining serogroups O34 and O174 
have to our knowledge not previously been described for 
any category of diarrheagenic E. coli. The strains that had O 
groups commonly found in ETEC were statistically more 
often CF positive than strains that either possessed an O 
serogroup not commonly found in ETEC or were non-
typeable (p < 0.0070). An H flagellar antigen was detected 
in 31 strains. The most common H-antigen was H9 (n = 9); 
eight of these strains were O8 serogroup and six of these 
strains were O8:H9 LT/CS17 which is a common ETEC 
phenotype and probably constituted a clone that circulated 
in Bolivia from 2002 to 2005. Other common H-antigens 
were H16 (n = 4), all of which were O6: H16, H40 (n = 5) 
and H45 (n = 2). 
The results of the antimicrobial susceptibility of the 
ETEC strains are shown in Table 1. Several of the strains 
were resistant to many antimicrobial drugs. The highest re-
sistance rate was found for ampicillin (53.5%; n = 23), fol-
lowed by ampicillin-sulbactam (46.5%; n = 20), trimetho-
prim-sulfamethoxazole (32.5%; n = 14), tetracycline (28 %; 
n = 12) and chloramphenicol (14%; n = 6). Most strains were 
not resistant to nalidixic acid, gentamicin, and cefoxitin and 
all the tested strains were susceptible to ciprofloxacin.
DISCUSSION
In our analysis of the 43 ETEC strains from Bolivia we 
found an unusually high prevalence of LT-only strains. 
LT, ST and LT/ST strains worldwide often occur at com-
parable frequencies,19 but LT strains have previously been 
reported to be more common in South American surveys 
of ETEC prevalence than in surveys in Asia and Africa21,22 
and recently an increase in LT strains also in Bangladesh 
was reported.23 The observed percentage of CF positive and 
negative strains is in agreement with other findings with 
approximately 2/3 of the strains expressing known CFs. 
The most common CFs were CFA/I and CS17 and while 
CFA/I always is one of the most commonly detected CF 
in surveys worldwide the high prevalence of both CS17 
and LT-only strains in this collection seemed to be due 
to an unusually high frequency of LT/CS17 strains. CS21 
was commonly detected by PCR but less commonly by dot 
blot as reported earlier.14 These results may be due to the 
observed variability in the coding region for CS21.8,24 The 
high prevalence of PCR positive CS21 strains among the 
Bolivian strains is in agreement with that observed in other 
countries in Asia and South America where CS21 frequen-
cies between 19% to 36.5% have been reported in ETEC 
strain collections.25-27
There was a large variation of serotypes among the 43 
ETEC strains. Unlike the genes for toxins and CFs, which 
are usually plasmid encoded, the O and H biosynthetic 
genes are chromosomal.28 This suggests a high degree of 
clonal diversity of disease-associated ETEC in this geo-
graphic area over a relatively short period of time. Nota-
bly, several of the serotypes detected were not those typi-
cally associated with ETEC. Since there is only evidence of 
protection against homologous O groups and no evidence 
that ETEC O- and H-antigens are protective against heter-
ologous serotypes,28-30 there would seem to be little to gain 
from incorporation of specific O- or H-antigens into a vac-
cine against ETEC.
We found a relation between serotype, toxin and CF 
profile. Thus, O8:H9 strains commonly expressed LT and 
CS17 (6 strains) while the O78:HNM strain expressed LT, 
STh and CFA/I and carried the gene for CS21 (4 strains). 
We also detected three O6:H16 strains that expressed LT, 
STh and CS1 + CS3 + CS21 which has previously been re-
ported to be the most frequently detected and widely dis-
tributed ETEC phenotype worldwide.19
ETEC strains that have identical toxin and CF profiles 
have been proposed to be genetically closely related.31,32 The 
results from this and other studies on ETEC serotypes sup-
port that strains with certain toxin and CF profiles often 
have certain O- and H-antigens indicating that there might 
be a genetic relationship between strains with similar phe-
notypes regardless of where they are found in the world. 
We found a high level of antibiotics resistance in the 
Bolivian ETEC strains (Table 1). It is reasonable that this 
multiresistance of ETEC might emerge to classical antibi-
otics such as ampicillin, tetracycline, and trimethoprim-
sulfamethoxazole33 since they have been widely used in Bo-
livia during the past few years. For instance the Integrated 
Management of Childhood Illness (AIEPI) manual recom-
mends the use of trimethoprim-sulfamethoxazole as the 
first line antibiotic for the treatment of bloody diarrhea34 
and tetracycline is prescribed for the treatment of different 
infectious diseases. Therefore, these antibiotics are widely 
used in medical settings in Bolivia. 
Initially, doxycycline was recommended for the treat-
ment of travelers’ diarrhea but recently the fluoroqui-
nolones have become the drug of choice. However, these 
drugs are not recommended for children and it should 
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be taken into consideration that in spite of the minimal 
use of quinolones in Bolivia, we detected nalidixic acid-
resistant ETEC strains. The quinolone resistance in E. coli 
has mainly been associated with mutations in the gyrA and 
parC genes. Strains resistant to nalidixic acid are likely to 
have at least one mutation of the gyrA gene. If quinolones 
are used as a first drug of choice for diarrhea in countries 
where the use of antibiotics is not regulated, a rapid emer-
gence of quinolone resistance will likely occur. Therefore 
it is important to continue the surveillance of enteric bac-
terial pathogens for quinolone resistance.35 Rifaximin is a 
non-absorbable antimicrobial agent which has been shown 
to be effective for treatment of severe episodes of bacterial 
diarrhea in children in developed countries,36 and accord-
ing to our results, resistance to ciprofloxacin is still uncom-
mon in Bolivia. 
Based on our results, we recommend a better control 
of prescribed antibiotics in Bolivia. Since most mild di-
arrhea cases are indeed successfully managed with oral 
rehydration therapy, our results further support that an-
timicrobial treatment should not be considered for treat-
ment of ETEC diarrhea unless for more severe or persis-
tent diarrhea cases.4
Finally, we found that there was a statistically signifi-
cant correlation (Table 2) between expression of CFs and 
presence of antimicrobial resistance, since 82% (23/28) of 
the CF positive strains harbored antimicrobial resistance, 
in contrast to the CF negative strains which only were re-
sistant in 47% (7/15) of the cases. This finding may suggest 
that resistance genes might be located on ETEC virulence 
plasmids. Presence of CFs has previously been found to 
correlate to disease37 and we found in this study that a high 
proportion of the ETEC strains that all were collected from 
hospitalized children expressed known CFs. Since these 
strains may also be more likely to also carry antibiotic re-
sistance genes, our results further implicate that vaccina-
tion is a better solution than antimicrobial treatment. 
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